Arista Cereal Technologies (Arista) has revealed that it has achieved significant progress in commercialising its high-fibre wheat.

Arista is a joint-venture (JV) company, which was formed by the seed company Limagrain, and Australia’s national research agency CSIRO.

The two companies collaborated two decades ago to carry out fundamental research in wheat starch, and in 2006 they further integrated their efforts in order to develop and commercialise wheat with direct consumer health benefits.

Arista CEO Eric Vaschalde said: “Arista shareholders, with their extensive experience in intellectual property protection, and long-term focus, are highly committed to this portfolio, which is a result of their previous 20 years of research.”

The company further explained that its high-fibre contains high levels of amylose, which is a starch molecule that occurs naturally in wheat.

“Our owners view high-amylose wheat as a priority for their organisations to close the global fibre gap.”

The starch molecule acts as a fibre and creates a positive impact on both digestive and glycemic health and chronic diseases associated with inadequate fibre consumption.

“Our owners view high-amylose wheat as a priority for their organisations to close the global fibre gap,” Vaschalde added.

Arista is working with breeding companies located in the US, Europe and Australasia to commercialise high-fibre wheat worldwide.

In North America, Arista has partnered with Bay State Milling to bring high-fibre wheat ingredients to market.

Arista further noted that commercial quantities will be available for a variety of food applications later this year.